# Dnipro State Medical University

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/dnipro-state-medical-university/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 83 |
| Citations | 160,141 |
| City | Dnipro |
| Country | UA |
| Description | Dnipro State Medical University is a research organisation in Dnipro, UA. OpenAlex records 3,351 works and 160,141 citations for it. 1,756 researchers list it as their most recent affiliation. |
| Homepage | https://dmu.edu.ua |
| OpenAlex ID | https://openalex.org/I905458539 |
| Region | Dnipropetrovsk |
| Researchers | 1,756 |
| ROR ID | https://ror.org/0469ncz24 |
| Type | healthcare |
| Works | 3,351 |

## University papers

- [Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma](https://scholariq.org/papers/ipilimumab-plus-dacarbazine-for-previously-untreated-metastatic-melanoma/)
- [RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer](https://scholariq.org/papers/ribbon-1-randomized-double-blind-placebo-controlled-phase-iii-trial-of/)
- [Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial](https://scholariq.org/papers/docetaxel-plus-nintedanib-versus-docetaxel-plus-placebo-in-patients-with/)
- [Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer](https://scholariq.org/papers/effect-of-first-line-serplulimab-vs-placebo-added-to-chemotherapy-on-survival-in/)
- [Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer](https://scholariq.org/papers/trifluridine-tipiracil-and-bevacizumab-in-refractory-metastatic-colorectal/)
- [Alectinib in Resected <i>ALK</i> -Positive Non–Small-Cell Lung Cancer](https://scholariq.org/papers/alectinib-in-resected-i-alk-i-positive-non-small-cell-lung-cancer/)
- [Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer](https://scholariq.org/papers/randomized-phase-iii-placebo-controlled-trial-of-letrozole-plus-oral/)
- [A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy](https://scholariq.org/papers/a-randomized-phase-iii-study-evaluating-the-efficacy-and-safety-of-nepa-a-fixed/)
- [Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study](https://scholariq.org/papers/efficacy-and-safety-of-nepa-an-oral-combination-of-netupitant-and-palonosetron/)

## University top topics

Showing 8 of 25.

- [Human Health and Disease](https://scholariq.org/topics/human-health-and-disease/)
- [Medical and Biological Sciences](https://scholariq.org/topics/medical-and-biological-sciences/)
- [Healthcare Systems and Public Health](https://scholariq.org/topics/healthcare-systems-and-public-health/)
- [Military Technology and Strategies](https://scholariq.org/topics/military-technology-and-strategies/)
- [Legal and Regulatory Analysis](https://scholariq.org/topics/legal-and-regulatory-analysis/)
- [Linguistic, Cultural, and Literary Studies](https://scholariq.org/topics/linguistic-cultural-and-literary-studies/)
- [Chronic Obstructive Pulmonary Disease (COPD) Research](https://scholariq.org/topics/chronic-obstructive-pulmonary-disease-copd-research/)
- [Neurological Disorders and Treatments](https://scholariq.org/topics/neurological-disorders-and-treatments-2/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.